Rare diseases
Investigational molecules
Locations
S S:t Lars, S:t Larsgatan 49 B, Linkopings S:t Lars, 582 24 Linkoping, Sweden
Research activity includes treatment strategies for newly diagnosed glioblastoma, with attention to MGMT promoter methylation, IDH-wildtype disease, and the use of radiotherapy with systemic therapy. The clinical focus also extends to tumor treating fields in the management of aggressive central nervous system malignancy.
Interest is centred on survival-focused treatment pathways for high-grade glioma and multimodal oncologic care.
Region Oestergoetland runs clinical trials in conditions such as Glioblastoma, Perineal injury, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaSwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
